WordNet

street name for lysergic acid diethylamide (同)back breaker, battery-acid, dose, dot, Elvis, loony toons, Lucy in the sky with diamonds, pane, superman, window pane, Zen
any of various water-soluble compounds having a sour taste and capable of turning litmus red and reacting with a base to form a salt
having the characteristics of an acid; "an acid reaction"

PrepTutorEJDIC

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/06/17 14:18:42」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Evaluation of crystallographic orientation of biological apatite in vertebral cortical bone in ovariectomized cynomolgus monkeys treated with minodronic acid and alendronate.

Tanaka M1, Matsugaki A, Ishimoto T, Nakano T.
Journal of bone and mineral metabolism.J Bone Miner Metab.2015 Apr 3. [Epub ahead of print]
Quantitative analysis of the orientational distribution of biological apatite (BAp) crystals is proposed as a new index of bone quality. This study aimed to analyze BAp c-axis orientation in ovariectomized (OVX) monkeys treated with amino-bisphosphonates minodronic acid and alendronate as reference.
PMID 25837430

Pharmacokinetics and tolerability of minodronic Acid tablets in healthy chinese subjects and food and age effects on the pharmacokinetics.

Zhou Y1, He X1, Li H1, Ni Y1, Xu M1, Sattar H1, Chen H2, Li W3.
Clinical therapeutics.Clin Ther.2015 Apr 1;37(4):869-76. doi: 10.1016/j.clinthera.2015.01.015. Epub 2015 Mar 5.
PURPOSE: Minodronic acid is a third-generation bisphosphonate being developed for the treatment of osteoporosis. The aim of this study was to evaluate the pharmacokinetic profiles and tolerability of minodronic acid in healthy subjects, as well as to assess the effects of food and age on the pharmac
PMID 25748293

Crystal structure of zwitterionic 3-(2-hy-droxy-2-phospho-nato-2-phosphono-eth-yl)imidazo[1,2-a]pyridin-1-ium monohydrate (minodronic acid monohydrate): a redetermination.

Airoldi A1, Bettoni P1, Donnola M1, Calestani G2, Rizzoli C2.
Acta crystallographica. Section E, Crystallographic communications.Acta Crystallogr E Crystallogr Commun.2015 Jan 1;71(Pt 1):51-4. doi: 10.1107/S2056989014026863. eCollection 2015.
In a previous study, the X-ray structure of the title compound, C9H12N2O7P2·H2O, was reported [Takeuchi et al., (1998 ▶). Chem. Pharm. Bull. 46, 1703-1709], but neither atomic coordinates nor details of the geometry were published. The structure has been redetermined with high precision as its de
PMID 25705449

Minodronic acid
	IUPAC name (1-Hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid
	Other names Minodronate; YM 529
Identifiers
CAS number	180064-38-4 , 155648-60-5 (hydrate)
PubChem	130956
ChemSpider	115805
ChEMBL	CHEMBL319144
Jmol-3D images	Image 1
	SMILES O=P(O)(O)C(O)(P(=O)(O)O)Cc1cnc2ccccn12 ;
	InChI InChI=1S/C9H12N2O7P2/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18) ; Key: VMMKGHQPQIEGSQ-UHFFFAOYSA-N ;
Properties
Molecular formula	C9H12N2O7P2
Molar mass	322.15 g mol−1
	Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
	(verify) (what is: /?)
	Infobox references